Allstate (ALL) PT Lowered to $225 at Morgan Stanley
Get Alerts ALL Hot Sheet
Price: $259.87 +1.54%
Rating Summary:
15 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
15 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Bob Huang lowered the price target on Allstate (NYSE: ALL) to $225.00 (from $229.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Allstate Says Impersonation Scams Lead Top 2026 Scam Cases: How to Spot the Warning Signs
- Regeneron Pharma (REGN) PT Raised to $875 at Baird
- Eli Lilly (LLY) PT Raised to $1,600 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share